Mayne Pharma reported $260.5M in Operating Expenses for its second fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Ansell ANN:AU $ 1.23B 329.57M
Cochlear COH:AU $ 586.3M 37.4M
CSL CSL:AU $ 5.52B 247.4M
Ecofibre Ltd EOF:AU 24.43M 8.46M
Healius Ltd HLS:AU $ 976.3M 141.3M
Integral Diagnostics Ltd IDX:AU 161.31M 3.22M
Medical Developments International Ltd MVP:AU 19.07M 7.3M
Nanosonics Ltd NAN:AU $ 57.29M 8.12M
Next Science Ltd NXS:AU 14.11M 5.93M
Polynovo Ltd PNV:AU 16.26M 2.61M
Probiotec Ltd PBP:AU 78.88M 6.53M
Ramsay Health Care RHC:AU $ 6B 49.8M
ResMed RMD:AU $ 955.43M 325.19M
Sigma Healthcare Ltd SIG:AU 1.77B 12.33M
Sonic Healthcare SHL:AU $ 3.55B 151.62M
Telix Pharmaceuticals Ltd TLX:AU 49.99M 17.14M